Long-term survival of patients with pulmonary disease undergoing coronary artery bypass surgery
|
|
- Katrina Brooks
- 5 years ago
- Views:
Transcription
1 European Journal of Cardio-Thoracic Surgery 43 (2013) doi: /ejcts/ezs454 Advance Access publication 24 October 2012 ORIGINAL ARTICLE Long-term survival of patients with pulmonary disease undergoing coronary artery bypass surgery Francesca O Boyle, Neeraj Mediratta, John Chalmers, Omar Al-Rawi, Kamlesh Mohan, Matthew Shaw and Michael Poullis* Department of Cardiac Surgery, Liverpool Heart and Chest Hospital, Liverpool, UK *Corresponding author. Department of Cardiac Surgery, Liverpool Heart and Chest Hospital, Thomas Drive, Liverpool L14 3PE, UK. Tel: ; fax: ; mike.poullis@lhch.nhs.uk (M. Poullis). Received 7 May 2012; received in revised form 16 June 2012; accepted 25 June 2012 Abstract OBJECTIVES: We sought to investigate the long-term survival of patients with obstructive, restrictive and chronic obstructive pulmonary disease (COPD) as defined by the Global Initiative for Chronic Obstructive Lung Disease (GOLD). METHODS: A prospective database was retrospectively analysed and cross-correlated with the UK strategic tracking service to evaluate survival after primary coronary artery bypass grafts (CABG). Univariate and multivariate Cox regression analyses were performed. Three separate multivariate analyses were performed: COPD GOLD criteria for obstructive and/or restrictive lung disease, forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC) and the FEV1/FVC ratio to investigate the effect of FEV1 and FVC individually. RESULTS: We analysed primary CABG procedures. The median follow-up was 7 years. Univariate analysis demonstrated that obstructive (P < ), restrictive (P < ) and mixed obstructive and restrictive pulmonary disease (P < ), and COPD as defined by the GOLD criteria (P < ), are all significant factors determining long-term survival. Cox regression analysis identified age, diabetes, moderate LV, poor LV, peripheral vascular disease, dialysis, left internal mammary artery (LIMA) usage, EuroSCORE, cardiopulmonary bypass and creatinine kinase muscle-brain isoenzyme as significant factors in addition to pulmonary disease that determine long-term survival. Moderate and severe COPD defined by GOLD criteria were significant factors determining long-term survival, but mild COPD had no significant effect. Obstructive and restrictive lung disease were both significant factors determining long-term survival. Restrictive lung disease, however, carried a greater prognostic significance (higher hazard ratio 2.2 vs 1.6) than obstructive. LIMA utilization in patients with COPD was not associated with an increased intensive care unit stay, re-intubation rate or in-hospital mortality rate. CONCLUSIONS: Pulmonary disease is a significant factor determining long-term survival. Patients with severe COPD still have a relatively good long-term survival and should not be denied surgery. LIMA utilization in patients with COPD results in a significantly increased long-term survival, without an increased intensive care unit stay, re-intubation rate or in-hospital mortality rate. Keywords: Coronary Survival Chronic obstructive pulmonary disease INTRODUCTION Pulmonary disease is known to be a risk factor for in-hospital mortality, hence its inclusion in the EuroSCORE and Southern Thoracic Society (STS) risk models. A number of the risk factors in the EuroSCORE have previously been identified by Cox regression analysis as possible significant factors [1] with regard to long-term survival, leading to a number of authors [2, 3], utilizing EuroSCORE as a possible predictor of long-term survival despite its derivation being based on in-hospital operative mortality. This concept has been recently extended, via the addition of diabetes, left internal mammary artery (LIMA) usage, body mass index (BMI) and postoperative creatinine kinase (muscle brain; CKMB) in its calculation [4]. Little consensus existed in the diagnosis of chronic obstructive pulmonary disease (COPD) until the publication of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria, which are based on spirometric findings [5]. We sought to investigate the role of pulmonary disease as a prognostic factor with regard to long-term survival after primary coronary artery bypass surgery. MATERIALS AND METHODS Local institutional review board approval was granted for this study. Database A prospective institutional cardiac surgery database, validated by the hospital data analysis department and accredited by the The Author Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
2 698 F. O Boyle et al. / European Journal of Cardio-Thoracic Surgery Society of Cardiothoracic Surgeons of Great Britain and Ireland (SCTS) was utilized in conjunction with the national strategic tracking service for long-term follow-up that exists in the UK, as has been described previously [6 10]. All patients have their forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) measured prior to surgery. Patients Patients who had undergone isolated coronary artery bypass grafts (CABG) only were included, N = , between 1st April 1997 and 31st March Benchmarking We benchmarked our in-hospital mortality figures against the UK national results ( Methodology The characteristics of the patients in this study are shown in Table 1. Definitions Chronic lung disease can be classified as chronic obstructive lung disease (COPD, GOLD criteria [5]), or obstructive and/or restrictive ( physiological criteria [11]), as defined below. GOLD criteria Normal spirometry: FEV1/FVC ratio > 70%, and FEV1 80% Mild COPD: FEV1/FVC ratio < 70%, and FEV1 80% Moderate COPD: FEV1/FVC ratio < 70%, and 50% FEV1 < 80% Severe COPD: FEV1/FVC ratio < 70%, and FEV1 < 50% Physiological criteria Obstructive lung disease: relative FEV1 < 70%, and FVC > 70% Restrictive lung disease: FVC < 70%, and relative FEV1 > 70% Mixed obstructive and restrictive lung disease: FVC < 70%, and relative FEV1 < 70% The differences in GOLD criteria and physiological criteria are diagrammatically shown in Fig. 1. Long-term survival Univariate analysis. Kaplan Meier survival curves were constructed, for patients with restrictive, obstructive and mixed obstructive and restrictive pulmonary disease, and for patients with COPD as defined by the GOLD criteria (Fig. 2). Table 1: Pre-, peri- and postoperative characteristics of patients in the study group Data (N = ) Preoperative Age (years) ( ) Female (%) 19.6 BMI (kg/m 2 ) 28.4 ( ) Heart failure (%) 0.14 Critical preoperative state (%) 0.13 Previous CVA (%) 0.1 Diabetes (%) 36.7 Preoperative dialysis (%) 0.4 Previous MI (%) 48.9 PVD (%) 13.6 Hypertension (%) 60.1 COPD (%) a None Mild 7.66 Moderate 11 Severe 1.85 Type of lung disease (%) None 85.0 Obstructive 13.2 Restrictive 1.01 Mixed 0.83 FEV1 (%) 71.7 (62 97) Preoperative IABP (%) 1.3 Ejection Good (%) 59.7 Fraction Moderate (%) 31.4 Poor (%) 8.9 Previous PCI (%) 6.4 Status Elective (%) 80.5 Urgent (%) 18.2 Emergency (%) 1.3 Log EuroSCORE 4.7 (0 17.7) Operative LIMA (%) 91.9 No. of grafts 3.3 ( ) CPB time (min) 109 (46 173) Postoperative CKMB 30.3 (0 139) ITU LOS (days) (0 9.7) Hospital LOS (days) 9.5 (0 32) Mortality (%) 2.1 Median follow-up (years) 7.02 Continuous variables are shown as mean with 95% confidence intervals shown in brackets. Categorical variables are shown as a percentage. a As defined by the GOLD criteria. BMI: body mass index; CVA: cerebral vascular accident; MI: myocardial infarction; PVD: peripheral vascular disease; IABP: intra-aortic balloon pump; PCI: percutaneous coronary intervention; LIMA: left internal mammary artery; CPB: cardiopulmonary bypass; CKMB: creatinine kinase myocardial isoenzyme; ITU LOS: intensive care length of stay. The discrimination abilities of FEV1, FVC, FEV1/FVC ratio and GOLD criteria were assessed by the Somers Dxy test. Multivariate analysis. Stepwise Cox proportional hazards regression analysis was utilized to identify potential significant determining factors with regard to long-term survival. Entry criteria had a significance at P < 0.05, and removal criteria had a significance at P > 0.1 (Table 2). The effect of the COPD GOLD
3 F. O Boyle et al. / European Journal of Cardio-Thoracic Surgery 699 Table 2: Cox regression analysis of survival using (A) COPD GOLD criteria, (B) Obstructive and/or restrictive analysis disease and (C) FEV1, FVC and FEV1/FVC analysis Covariate HR 95% CI of HR P-value Figure 1: (A) Pulmonary function classified by physiological criteria or (B) GOLD criteria. FEV1 cannot be higher than FVC, by definition, and hence no patients will be above the line FEV1/FVC = 1. criteria stage and obstructive and/or restrictive lung disease was analysed separately with regard to long-tem survival, and their effects were plotted at the mean of the covariates (Fig. 3). The effect of on- or off-pump is shown in Fig. 4. Statistical software All statistical analyses other than the neuronal network and Somers Dxy tests were performed with MedCalc for Windows, version (MedCalc Software, Mariakerke, Belgium). Somers C statistic and Dxy was performed with R ( (A) COPD GOLD criteria Age < Diabetes < Moderate LV < Poor LV < PVD Dialysis < LIMA < EuroSCORE < CKMB < CPB Moderate COPD Severe COPD < (B) Obstructive and/or restrictive analysis Age < Diabetes < Moderate LV < Poor LV < PVD Dialysis < LIMA < EuroSCORE < CKMB < Restrictive < Obstructive < (C) FEV1, FVC and FEV1/FVC analysis Age < Diabetes < Moderate LV < Poor LV < PVD Dialysis < LIMA < EuroSCORE < CKMB < FEV < FEV1/FVC ratio LV: left ventricular function; PVD: peripheral vascular disease; LIMA: left internal mammary artery; CKMB: creatinine kinase muscle-brain type; CPB: cardiopulmonary bypass; HR: hazard ratio; CI: confidence interval; COPD: chronic obstructive pulmonary disease. RESULTS One hundred percent long-term follow-up via the national strategic tracing service was achieved. Benchmarking of our institutional mortality rates compared with the UK did not reveal any differences ( part of the continuous UK cardiac surgery quality assessment programme by the society of cardiothoracic surgeons). The logistic EuroSCORE ranged from to , mean 4.743, 95% confidence interval: and 90% were 10. Long-term follow-up was from 6 months to 12 years, mean 6.6 years and median 7 years. Figure 1 demonstrates that the GOLD criteria and the physiological criteria for the classification of respiratory function are different, and hence analysis was done in multiple different ways. A total of 2742 patients had mild, moderate or severe COPD, of which the majority, 1766 were purely obstructive in nature. Long-term survival Univariate. Kaplan Meier survival curves demonstrate that obstructive (P < ), restrictive (P < ) and mixed obstructive and restrictive pulmonary disease (P < ), and COPD as defined by the GOLD criteria (P < ), are all significant factors determining long-term survival (Fig. 2). The overall sensitivity and specificity of FEV1 for predicting long-term survival were 61.1 and 62.8%, respectively, with a C statistic of 0.381, and a Dxy of The overall sensitivity and specificity of FVC for predicting long-term survival were 43.5 and 70.8%, respectively, with a C statistic of 0.41, and a Dxy of The overall sensitivity and specificity of FEV1/FVC ratio for predicting long-term survival were 42.5 and 76.8%, respectively, with a C statistic of 0.43, and a Dxy of 0.15.
4 700 F. O Boyle et al. / European Journal of Cardio-Thoracic Surgery Figure 2: Kaplan Meier survival curves for (A) restrictive, (B) obstructive, (C) mixed obstructive and restrictive pulmonary disease and (D) COPD as defined by the GOLD criteria. The overall sensitivity and specificity of moderate or severe GOLD criteria for predicting long-term survival were 17.4 and 88.8%, respectively, with a C statistic of The above analysis implies that the GOLD criteria have a high specificity for predicting poor long-term survival, and the FEV1 has poor sensitivity and specificity for predicting long-term survival. Cox regression analysis. Cox regression analysis to determine the importance of respiratory function with regard to long-term survival is shown in Table 2. Three separate analyses were performed: COPD GOLD criteria, obstructive and/or restrictive lung disease, and FEV1, FVC and the FEV1/FVC ratio to investigate the effect of FEV1 and FVC individually. All three analyses identified age, diabetes, moderate LV, poor LV, PVD, dialysis, LIMA usage, EuroSCORE and CKMB as significant factors, in addition to pulmonary disease, influence longterm survival. Stepwise regression excluded female sex, BMI and hypertension were excluded from the models. Moderate and severe COPD defined by GOLD criteria were significant factors determining long-term survival, and mild COPD had no significant effect (Table 2A and Fig. 3A). Obstructive and restrictive lung disease were both significant factors determining long-terms survival (Fig. 3B D). Restrictive lung disease, however, carried a greater prognostic significance (higher hazard ratio) than obstructive lung disease (Table 2). FEV1 and FEV1/FVC ratio were significant factors determining long-term survival; however, a significant interaction existed between FVC and FEV1 as demonstrated by the ratio FEV1/FVC being of more significance than FVC by itself (Table 2C). The effect of on- or off-pump was only shown to be a significant factor when respiratory function was analysed with the use of the GOLD criteria (Table 2 and Fig. 4A). Subset analysis with patients classified as having COPD defined by GOLD criteria or not revealed that off-pump surgery was a significantly beneficial factor with regard to long-term survival in patients with no COPD (Fig. 4B), but had no impact in patients with COPD. LIMA usage was shown to be a significant factor determining of long-term survival regardless of the classification of respiratory disease utilized in the analysis. Subset analysis with patients classified as having or not having COPD defined by GOLD criteria revealed LIMA usage to be prognostically significantly beneficial regardless of the pulmonary status (data not shown). DISCUSSION COPD as defined by the GOLD criteria is a significant determinant of long-term survival, when moderate or severe in nature. Restrictive lung disease is of more prognostic importance than obstructive lung disease. Quantification of pulmonary dysfunction can be done in a number of ways, and hence our analysis by GOLD criteria for obstructive and/poor restrictive and on raw spirometric data (FEV1 and FVC). All three analyses identified the same non-respiratory factors determining long-term survival. Patients with severe
5 F. O Boyle et al. / European Journal of Cardio-Thoracic Surgery 701 Figure 3: The effect of (A) COPD GOLD criteria stage, (B) obstructive, (C) restrictive and (D) mixed obstructive and restrictive lung disease on long-tem survival plotted at the mean of the covariates. COPD as defined by the GOLD criteria had a 10-year survival of 50%, and patients with obstructive and restrictive lung disease had a 10-year survival rate of 70%. This implies that despite their having higher in-hospital predicted mortality, patients with pulmonary disease should not be denied surgery as their long-term outcomes are relatively good, despite pulmonary function being a significant factor determining survival. Previous large studies have failed to use quantifiable definitions and frequently relied on a clinical label of COPD [12], as no internationally agreed criteria existed until recently, resulting in different definitions of COPD depending on the author [13] and/ or have been underpowered due to the sample size [14]. COPD has been shown to be a significant factor determining long-term survival in patients with ischaemic heart disease patients [15], but no publications exist with regard to the prognostic importance in CABG patients of the GOLD criteria and obstructive and/or restrictive lung disease. Obstructive and restrictive lung disease represent different pathological processes. Analysis of the restrictive and obstructive components separately, as the GOLD classification system combined them, identifies that restrictive lung disease implies a worse long-term survival due to a higher hazard ratio on Cox analysis. It should be noted that FEV1 and FVC are continuous variables and using an arbitrary cut of values, as used in the GOLD and obstructive and/or restrictive classification systems, may introduce errors in risk prediction for individuals who fall near the artificial cut-off levels. The use of the internal mammary artery is known to be associated with increased survival post-cabg; however, it has not been included in a number of previous long-term prediction studies [16 18]. Concerns about LIMA usage in patients with COPD exist due to the concerns about pulmonary dysfunction. Multivariate analysis revealed that LIMA usage is not a risk factor in patients with COPD with regard to in-hospital mortality (data not shown), but is a significant factor determining long-term survival regardless of the COPD status. The number of patients with bilateral internal mammary arteries (BIMAs) was too small in our data set to analyse. Intraoperative myocardial damage is the main cause of cardiac dysfunction post-cardiac surgery, be it myocardial stunning, inadequate cardioplegia or coronary graft dysfunction. The finding that CKMB was a significant factor affecting the longterm outcome demonstrates the importance of intraoperative myocardial protection and the coronary anastomosis technique, and has been previously identified as a significant factor affecting long-term survival [19]. Concerns about postoperative morbidity, mainly respiratory complications and mortality in patients with COPD having their
6 702 F. O Boyle et al. / European Journal of Cardio-Thoracic Surgery pulmonary dysfunction makes comparison between different publications difficult. Pulmonary disease is a significant factor determining longterm survival. Patients with severe COPD still have a relatively good long-term survival and should not be denied surgery. LIMA utilization in patients with COPD results in a significantly increased long-term survival, without an increased intensive care unit stay, re-intubation rate or in-hospital mortality rate. LIMITATIONS We do not have the cause of death of the patients, a frequent limitation of retrospective analysis; however, our series is large, prospective, consecutive and features 100% long-term follow-up. Diffusion studies were not available for any of the patients. Very few patients received BIMA grafts, and so this factor could not be analysed without introducing a statistical error to a lack of power. We are unable to account for the patient selection bias, a limitation of all retrospective analyses. We made no attempt to break down the follow-up period into time intervals as have been done previously [1, 16, 20]. The 13-year time period that the patients in this study were recruited from may introduce a time factor error. This is a common confounding factor of any large study over a prolonged period of time. Conflict of interest: none declared. REFERENCES Figure 4: The effect of cardiopulmonary bypass on long-tem survival plotted at the mean of the covariates in (A) all patients and (B) those with COPD, as classified by the GOLD criteria. LIMA artery harvested exist. Multivariate analysis regarding re-intubation the rate of length of intensive care stay and in-hospital mortality failed to revealed LIMA usage as a risk factor. Subset analysis of just patients with COPD concurred (data not shown). Debate continues with regard to the use of off-pump techniques. Multivariate analysis demonstrated that off-pump is not associated with a significant difference in the hospital mortality; however, the technique is associated with significantly improved long-term survival in our cohort. Subanalysis reveals that off-pump is significantly beneficial with regard to longterm survival in patients who do not have COPD, but was of no benefit in patients with COPD. We speculate that the significantly reduced long-term survival of patients with COPD overshadows the relatively smaller benefits offered by off-pump surgery. Smoking cessation, oral and inhalational bronchodilator therapy can allow patients to move from one GOLD criteria to another. We speculate, but have no supporting evidence, that pulmonary risk factor assessment and modification may improve the long-term survival. Previous publications frequently classify pulmonary disease using qualitative criteria, usually clinical opinion. We recommend that FEV1, FVC and preferably if available pulmonary diffusion should be utilized to classify patient s pulmonary disease by GOLD criteria, and restrictive or obstructive. Failure to quantify [1] Gao G, Wu Y, Grunkemeier GL, Furnary AP, Starr A. Long-term survival of patients after coronary artery bypass graft surgery: comparison of the pre-stent and post-stent eras. Ann Thorac Surg 2006;82: [2] Toumpoulis IK, Anagnostopoulos CE, Toumpoulis SK, DeRose JJ Jr, Swistel DG. EuroSCORE predicts long-term mortality after heart valve surgery. Ann Thorac Surg 2005;79: [3] De Maria R, Mazzoni M, Parolini M, Gregori D, Bortone F, Arena V et al. Predictive value of EuroSCORE on long term outcome in cardiac surgery patients: a single institution study. Heart 2005;91: [4] O Boyle F, Mediratta N, Fabri B, Pullan M, Chalmers J, McShane J et al. Long-term survival after coronary artery bypass surgery stratified by EuroSCORE. Eur J Cardiothorac Surg 2012;42: [5] Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23: [6] Fontaine E, McShane J, Page R, Shackcloth M, Mediratta N, Carr M et al. Aspirin and non-small cell lung cancer resections: effect on long-term survival. Eur J Cardiothorac Surg 2010;38:21 6. [7] Fontaine E, McShane J, Carr M, Shachcloth M, Mediratta N, Page R et al. Should we operate on microscopic N2 non small cell lung cancer? Interact CardioVasc Thorac Surg 2011;12: [8] Fontaine E, McShane J, Carr M, Shackcloth M, Mediratta N, Page R et al. Does positron emission tomography scanning improve survival in patients undergoing potentially curative lung resections for non-smallcell lung cancer? Eur J Cardiothorac Surg 2011;40: [9] Attaran S, Shaw M, Bond L, Pullan MD, Fabri BM. Does off-pump coronary artery revascularization improve the long-term survival in patients with ventricular dysfunction? Interact CardioVasc Thorac Surg 2010;11: [10] Attaran S, Saleh HZ, Shaw M, Bond L, Pullan MD, Fabri BM. Comparing the outcome of on-pump versus off-pump coronary artery bypass grafting in patients with preoperative atrial fibrillation. Interact CardioVasc Thorac Surg 2011;13: [11] Silbernagl S, Despopoulos A. Respiration, Color Atlas of Physiology. 6th edn. Stuttgart, Germany: Thieme, 2008, [12] Leavitt BJ, Ross CS, Spence B, Surgenor SD, Olmstead EM, Clough RA et al. Long-term survival of patients with chronic obstructive pulmonary
7 F. O Boyle et al. / European Journal of Cardio-Thoracic Surgery 703 disease undergoing coronary artery bypass surgery. Circulation 2006; 114:I [13] Angouras DC, Anagnostopoulos CE, Chamogeorgakis TP, Rokkas CK, Swistel DG, Connery CP et al. Postoperative and long-term outcome of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass grafting. Ann Thorac Surg 2010;89: [14] Medalion B, Katz MG, Cohen AJ, Hauptman E, Sasson L, Schachner A. Long-term beneficial effect of coronary artery bypass grafting in patients with COPD. Chest 2004;125: [15] Nishiyama K, Morimoto T, Furukawa Y, Nakagawa Y, Ehara N, Taniguchi R et al. Chronic obstructive pulmonary disease an independent risk factor for long-term cardiac and cardiovascular mortality in patients with ischemic heart disease. Int J Cardiol 2010;143: [16] Charytan DM, Yang SS, McGurk S, Rawn J. Long and short-term outcomes following coronary artery bypass grafting in patients with and without chronic kidney disease. Nephrol Dial Transplant 2010;25: [17] El Chami MF, Kilgo P, Thourani V, Lattouf OM, Delurgio DB, Guyton RA et al. New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft. J Am Coll Cardiol 2010;55: [18] Sheridan BC, Stearns SC, Rossi JS, D Arcy LP, Federspiel JJ, Carey TS. Three-year outcomes of multivessel revascularization in very elderly acute coronary syndrome patients. Ann Thorac Surg 2010;89: [19] Domanski MJ, Mahaffey K, Hasselblad V, Brener SJ, Smith PK, Hillis G et al. Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA 2011;305: [20] MacKenzie TA, Malenka DJ, Olmstead EM, Piper WD, Langner C, Ross CS et al. Prediction of survival after coronary revascularization: modeling short-term, mid-term, and long-term survival. Ann Thorac Surg 2009;87:
FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery
EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2010 FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery Nicholas L Mills, David A McAllister, Sarah Wild, John D MacLay,
More informationImportance of the third arterial graft in multiple arterial grafting strategies
Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular
More informationVentricular Arrhythmia After Cardiac Surgery
Journal of the American College of Cardiology Vol. 60, No. 25, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.08.1011
More informationOn-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery
On-Pump vs. Off-Pump CABG: The Controversy Continues Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-pump vs. Off-Pump CABG: The Controversy Continues Conflict
More informationImpaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events
Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts
More informationEuroSCORE Predicts Short- and Mid-Term Mortality in Combined Aortic Valve Replacement and Coronary Artery Bypass Patients
c 2009 Wiley Periodicals, Inc. 637 EuroSCORE Predicts Short- and Mid-Term Mortality in Combined Aortic Valve Replacement and Coronary Artery Bypass Patients Kimiyoshi J. Kobayashi, B.S., Jason A. Williams,
More informationIs bypass surgery needed for elderly patients with LMT disease? From the surgical point of view
CCT 2003 (Kobe) Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view Hitoshi Yaku, MD, PhD Department of Cardiovascular Surgery Kyoto Prefectural University of
More informationClinical material and methods. Copyright by ICR Publishers 2007
16847_JHVD_Biancari_3197_(116-121)_r1:Layout 1 21/3/07 17:07 Page 116 Predicting Immediate and Late Outcome after Surgery for Mitral Valve Regurgitation with EuroSCORE Jouni Heikkinen, Fausto Biancari,
More informationA Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery
A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery Arman Kilic, MD 1, Rika Ohkuma, MD 1, J. Trent Magruder, MD 1, Joshua C. Grimm, MD 1, Marc Sussman, MD 1, Eric B. Schneider, PhD 1,
More informationAssessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington
Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME
More informationSetting The setting was a hospital. The economic study was carried out in Australia.
Coronary artery bypass grafting (CABG) after initially successful percutaneous transluminal coronary angioplasty (PTCA): a review of 17 years experience Barakate M S, Hemli J M, Hughes C F, Bannon P G,
More informationORIGINAL PAPER. Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery
Nagoya J. Med. Sci. 79. 37 ~ 42, 2017 doi:10.18999/nagjms.79.1.37 ORIGINAL PAPER Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery Naoki Ozeki, Koji
More informationRevascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease
Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang
More informationOPCAB IS NOT BETTER THAN CONVENTIONAL CABG
OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA
More informationLack of Effect of Beta-blocker Therapy in Patients with ST-elevation Acute Myocardial Infarction in PCI Era
Lack of Effect of Beta-blocker Therapy in Patients with ST-elevation Acute Myocardial Infarction in PCI Era B. Bao 1, N. Ozasa 1, T. Morimoto 2, Y. Furukawa 3, M. Shirotani 4, H. Ogawa 5, C. Tei 6, H.
More informationCost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J
Cost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J Record Status This is a critical abstract of an economic evaluation that meets the
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationIntraoperative application of Cytosorb in cardiac surgery
Intraoperative application of Cytosorb in cardiac surgery Dr. Carolyn Weber Heart Center of the University of Cologne Dept. of Cardiothoracic Surgery Cologne, Germany SIRS & Cardiopulmonary Bypass (CPB)
More informationSupplementary Online Content
1 Supplementary Online Content Friedman DJ, Piccini JP, Wang T, et al. Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing
More informationChairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine
Leonard N. Girardi, M.D. Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine New York, New York Houston Aortic Symposium Houston, Texas February 23, 2017 weill.cornell.edu
More informationRelationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome
Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João
More informationThe Second Best Arterial Graft:
The Second Best Arterial Graft: A Propensity Analysis of the Radial Artery Versus the Right Internal Thoracic Artery to Bypass the Circumflex Coronary Artery American Association for Thoracic Surgery,
More informationLeft Internal Mammary Artery to the Left Anterior Descending Artery: Effect on Morbidity and Mortality and Reasons for Nonusage
Left Internal Mammary Artery to the Left Anterior Descending Artery: Effect on Morbidity and Mortality and Reasons for Nonusage Shishir Karthik, FRCS, Arun K. Srinivasan, FRCS, Antony D. Grayson, BS, Mark
More informationEACTS Adult Cardiac Database
EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list
More informationUnprotected Left Main Coronary Artery Disease in Patients With Low Predictive Risk of Mortality
Unprotected Left Main Coronary Artery Disease in Patients With Low Predictive Risk of Mortality Shun Watanabe, MD, Tatsuhiko Komiya, MD, Genichi Sakaguchi, MD, PhD, and Takeshi Shimamoto, MD, PhD Department
More informationTAVR y Enfermedad Coronaria. Mauricio G. Cohen, MD, FACC, FSCAI Director, Cardiac Catheterization Lab Associate Professor of Medicine
TAVR y Enfermedad Coronaria Mauricio G. Cohen, MD, FACC, FSCAI Director, Cardiac Catheterization Lab Associate Professor of Medicine CAD and AS Similar Pathological Processes CAD in TAVR Patients (n=390)
More informationCoronary Artery Bypass Grafting in Diabetics: All Arterial or Hybrid?
Coronary Artery Bypass Grafting in Diabetics: All Arterial or Hybrid? Dr. Daniel Navia M.D. Chief Cardiac Surgery Department ICBA, Buenos Aires Argentina, 2018 No disclosures 2 Current evidence The FREEDOM
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age
More informationPredictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery
Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT- Before Cardiac Surgery Sai Polineni, MPH; Devin M. Parker, MS; Shama S. Alam, PhD, MSc; Heather Thiessen-Philbrook, BMath, MMath;
More informationRandomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial
Randomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial Embargoed until 10:45 a.m. CT, Monday, Nov. 14, 2016 David
More informationRespiratory failure (RF), or prolonged mechanical ventilation,
CARDIOTHORACIC ANESTHESIOLOGY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS
More informationExercise treadmill testing is frequently used in clinical practice to
Preventive Cardiology FEATURE Case Report 55 Commentary 59 Exercise capacity on treadmill predicts future cardiac events Pamela N. Peterson, MD, MSPH 1-3 David J. Magid, MD, MPH 3 P. Michael Ho, MD, PhD
More informationDepartments of Cardiology, Clinical Governance, and Cardiac Surgery, The Cardiothoracic Centre-Liverpool, Liverpool, United Kingdom
Preoperative White Blood Cell Count is Independently Associated With Higher Perioperative Cardiac Enzyme Release and Increased 1-Year Mortality After Coronary Artery Bypass Grafting Nick Newall, MRCP,
More information8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None
Pre-op Evaluation for non cardiac surgery John Steuter, MD Disclosures None A quick review from 2007!! Fliesheret al, ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and are for Noncardiac
More informationSupplementary Online Content
Supplementary Online Content Inohara T, Manandhar P, Kosinski A, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter
More informationCoronary Artery Bypass Graft: Monitoring Patients and Detecting Complications
Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications Madhav Swaminathan, MD, FASE Professor of Anesthesiology Division of Cardiothoracic Anesthesia & Critical Care Duke University
More informationMitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation
Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation Matthew L. Williams, MD, Mani A. Daneshmand, MD, James G. Jollis, MD, John
More informationAnalysis of Mortality Within the First Six Months After Coronary Reoperation
Analysis of Mortality Within the First Six Months After Coronary Reoperation Frans M. van Eck, MD, Luc Noyez, MD, PhD, Freek W. A. Verheugt, MD, PhD, and Rene M. H. J. Brouwer, MD, PhD Departments of Thoracic
More informationDisclosures The PREVENT IV Trial was supported by Corgentech and Bristol-Myers Squibb
Saphenous Vein Grafts with Multiple Versus Single Distal Targets in Patients Undergoing Coronary Artery Bypass Surgery: One-Year Graft Failure and Five-Year Outcomes from the Project of Ex-vivo Vein Graft
More informationContemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology
Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology Damien J. LaPar, MD, MSc, Daniel P. Mulloy, MD, Ivan K. Crosby, MBBS, D. Scott Lim, MD,
More informationPreoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery?
Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery? Damien J. LaPar MD, MSc, James M. Isbell MD, MSCI, Jeffrey B. Rich MD, Alan M. Speir MD, Mohammed
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparative
More informationMarc Albert, Adrian Ursulescu, Ulrich FW Franke Department of Cardiovascular Surgery Robert-Bosch-Hospital, Stuttgart, Germany
The total arterial myocardial revascularization using bilateral IMA and the role of post-operative sternal stabilization to reduce wound infections in a large cohort study. Marc Albert, Adrian Ursulescu,
More informationA Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD
A Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD SK Singh MD MSc, DK Pujara MBBS, J Anand MD, WE Cohn MD, OH Frazier MD, HR Mallidi MD Division of Transplant & Assist
More informationEmergency surgery in acute coronary syndrome
Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
More informationPrediction of acute renal failure after cardiac surgery: retrospective cross-validation of a clinical algorithm
Nephrol Dial Transplant (2003) 18: 77 81 Original Article Prediction of acute renal failure after cardiac surgery: retrospective cross-validation of a clinical algorithm Bjørn O. Eriksen 1, Kristel R.
More informationPrapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital
Prapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital Only 20-30% of patients with lung cancer are potential candidates for lung resection Poor lung function alone ruled
More informationHeart Failure and COPD: Common Partners, Common Problems. Nat Hawkins Liverpool Heart and Chest Hospital
Heart Failure and COPD: Common Partners, Common Problems Nat Hawkins Liverpool Heart and Chest Hospital Disclosures: No conflicts of interest Common partners, common problems COPD in HF common partners
More informationSupplementary Table S1: Proportion of missing values presents in the original dataset
Supplementary Table S1: Proportion of missing values presents in the original dataset Variable Included (%) Missing (%) Age 89067 (100.0) 0 (0.0) Gender 89067 (100.0) 0 (0.0) Smoking status 80706 (90.6)
More informationCoronary atherosclerotic heart disease remains the number
Twenty-Year Survival After Coronary Artery Surgery An Institutional Perspective From Emory University William S. Weintraub, MD; Stephen D. Clements, Jr, MD; L. Van-Thomas Crisco, MD; Robert A. Guyton,
More informationUnprotected LM intervention
Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline
More informationThe Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting
Original Article The Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting Toshihiro Fukui, MD, Susumu Manabe, MD, Tomoki Shimokawa, MD,
More informationRespiratory Function Testing Is Safe in Patients With Abdominal Aortic Aneurysms.
Respiratory Function Testing Is Safe in Patients With Abdominal Aortic Aneurysms. Author Zagami, Debbie, Wilson, Jessica, Bodger, Alanna, Sriram, Krishna Published 2014 Journal Title Vascular and Endovascular
More informationA case-control study of readmission to the intensive care unit after cardiac surgery
DOI: 0.2659/MSM.88384 Received: 202.04.24 Accepted: 203.0.25 Published: 203.02.28 A case-control study of readmission to the intensive care unit after cardiac surgery Authors Contribution: Study Design
More informationLong-Term Survival of Patients After Coronary Artery Bypass Graft Surgery: Comparison of the Pre-Stent and Post-Stent Eras
Long-Term Survival of Patients After Coronary Artery Bypass Graft Surgery: Comparison of the Pre-Stent and Post-Stent Eras Guangqiang Gao, MD, PhD, YingXing Wu, MD, Gary L. Grunkemeier, PhD, Anthony P.
More informationMinimally invasive aortic valve replacement in high risk patient groups
Review Article Minimally invasive aortic valve replacement in high risk patient groups Daniel Fudulu, Harriet Lewis, Umberto Benedetto, Massimo Caputo, Gianni Angelini, Hunaid A. Vohra Department of Cardiac
More informationDoes Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?
Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles
More informationCORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW
CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):
More informationDr. Stuart McCorkell BSc FRCA FFICM Anaesthetic Department, Guy s & St. Thomas s NHS Foundation Trust 2017 POPS
Dr. Stuart McCorkell BSc FRCA FFICM Anaesthetic Department, Guy s & St. Thomas s NHS Foundation Trust Why assess (estimate) risk? Patient information and informed consent (patient, surgeon) Stratify resource
More informationDiagnostic, Technical and Medical
Diagnostic, Technical and Medical Approaches to Reduce CABG Related Stroke Pieter Kappetein, Michael Mack, M.D. Dept Thoracic Surgery, Rotterdam, The Netherlands Baylor Healthcare System Dallas, TX Background
More informationTransfusion & Mortality. Philippe Van der Linden MD, PhD
Transfusion & Mortality Philippe Van der Linden MD, PhD Conflict of Interest Disclosure In the past 5 years, I have received honoraria or travel support for consulting or lecturing from the following companies:
More informationThe MAIN-COMPARE Study
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationCopyright by ICR Publishers 2005
Does EuroSCORE Predict Length of Stay and Specific Postoperative Complications after Heart Valve Surgery? Ioannis K. Toumpoulis 1,2, Constantine E. Anagnostopoulos 1,2 1 Columbia University College of
More informationSURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS?
SURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS? Luigi Martinelli Chief, Dept. of Surgery Istituto Clinico Ligure di Alta Specialità RAPALLO During 1987 2006,
More informationThe MAIN-COMPARE Registry
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationPeriprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion
Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol
More informationImpact of Renal Dysfunction on Long-Term Survival After Isolated Coronary Artery Bypass Surgery
Impact of Renal Dysfunction on Long-Term Survival After Isolated Coronary Artery Bypass Surgery Ye Lin, MD,* Zhe Zheng, MD,* Yan Li, MD,* Xin Yuan, MD, Jianfeng Hou, MD, Shiju Zhang, MD, Hongguang Fan,
More informationPostoperative atrial fibrillation predicts long-term survival after aortic-valve surgery but not after mitral-valve surgery: a retrospective study
Open Access To cite: Girerd N, Magne J, Pibarot P, et al. Postoperative atrial fibrillation predicts long-term survival after aortic-valve surgery but not after mitral-valve surgery: a retrospective study.
More informationSevere left ventricular dysfunction and valvular heart disease: should we operate?
Severe left ventricular dysfunction and valvular heart disease: should we operate? Laurie SOULAT DUFOUR Hôpital Saint Antoine Service de cardiologie Pr A. COHEN JESFC 16 janvier 2016 Disclosure : No conflict
More informationBicuspid aortic root spared during ascending aorta surgery: an update of long-term results
Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,
More informationMyocardial enzyme release after standard coronary artery bypass grafting
Cardiopulmonary Support and Physiology Schachner et al Myocardial enzyme release in totally endoscopic coronary artery bypass grafting on the arrested heart Thomas Schachner, MD, a Nikolaos Bonaros, MD,
More informationCounterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece
John N. Nanas, MD, PhD Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece History of counterpulsation 1952 Augmentation of CBF Adrian and Arthur Kantrowitz, Surgery 1952;14:678-87
More informationDepartment of Cardiothoracic Surgery, Heart and Lung Center, Lund University Hospital, Lund, Sweden
Long-Term Outcome of the Mitroflow Pericardial Bioprosthesis in the Elderly after Aortic Valve Replacement Johan Sjögren, Tomas Gudbjartsson, Lars I. Thulin Department of Cardiothoracic Surgery, Heart
More informationParis, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators
Paris, August 28 th 2011 Is TAVI the definitive treatment in high risk patients? Impact Of Coronary Artery Disease In Elderly Patients Undergoing TAVI: Insight The Italian CoreValve Registry Gian Paolo
More informationLM stenting - Cypher
LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with
More informationEarly readmission for congestive heart failure predicts late mortality after cardiac surgery
Lee et al Perioperative Management Early readmission for congestive heart failure predicts late mortality after cardiac surgery Richard Lee, MD, MBA, Natalie Homer, BS, Adin-Cristian Andrei, PhD, Edwin
More informationImpact of Off-Pump Coronary Artery Bypass Graft Surgery on Postoperative Pulmonary Complications in Patients With Chronic Lung Disease
ADULT CARDIAC ORIGINAL ARTICLES: ADULT CARDIAC ADULT CARDIAC SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to
More informationOff-Pump Cardiac Surgery is not Dead
Off-Pump Cardiac Surgery is not Dead Gonzalo J. Carrizo, M.D. Fellow Cardiothoracic Surgery Division Cardiothoracic Surgery Department of Surgery University of Colorado Hopeman Lectureship September 10,2007
More informationDoes Coronary Artery Bypass Graft Surgery Improve Survival Among Patients With End-Stage Renal Disease?
Does Coronary Artery Bypass Graft Surgery Improve Survival Among Patients With End-Stage Renal Disease? Todd M. Dewey, MD, Morley A. Herbert, PhD, Syma L. Prince, RN, Carrie L. Robbins, RN, Christina M.
More informationDiabetes has long been described as an independent
Effect of Risk-Adjusted Diabetes on Mortality and Morbidity After Coronary Artery Bypass Surgery Chandrasahekhar Kubal, MRCS, Arun K. Srinivasan, FRCS, Antony D. Grayson, BS, Brian M. Fabri, FRCS(Ed),
More informationDoes ambroxol confer a protective effect on the lungs in patients undergoing cardiac surgery or having lung resection?
Interactive CardioVascular and Thoracic Surgery 18 (2014) 830 834 doi:10.1093/icvts/ivu061 Advance Access publication 12 March 2014 BEST EVIDENCE TOPIC THORACIC Does ambroxol confer a protective effect
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Bucholz EM, Butala NM, Ma S, Normand S-LT, Krumholz HM. Life
More informationOutcomes of off-pump versus on-pump coronary artery bypass grafting: Impact of preoperative risk
ACQUIRED CARDIOVASCULAR DISEASE Outcomes of off-pump versus on-pump coronary artery bypass grafting: Impact of preoperative risk Marek Polomsky, MD, a Xia He, MS, b Sean M. O Brien, PhD, b and John D.
More informationCritical Appraisal of Risk Adjusted Analysis and Public Reporting of Outcomes in Cardiac Surgery
Critical Appraisal of Risk Adjusted Analysis and Public Reporting of Outcomes in Cardiac Surgery University of Ottawa Heart Institute Jean Yves Dupuis, MD, FRCPC Cardiac Division of Anesthesiology Disclosure
More informationAccepted Manuscript. Coronary dialysis patients: CABG or PCI? A complex question for a complex scenario
Accepted Manuscript Coronary dialysis patients: CABG or PCI? A complex question for a complex scenario Francesco Formica, MD, Stefano D Alessandro, MD, FECTS. PII: S0022-5223(18)32554-6 DOI: 10.1016/j.jtcvs.2018.09.050
More informationUniversity of Bristol - Explore Bristol Research
Rogers, C., Capoun, R., Scott, L., Taylor, J., Angelini, G., Narayan, P.,... Ascione, R. (2017). Shortening cardioplegic arrest time in patients undergoing combined coronary and valve surgery: results
More informationMitral Valve Repair Does Hospital Volume Matter? Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Bogotá Colombia
Mitral Valve Repair Does Hospital Volume Matter? Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Bogotá Colombia Disclosures Edwards Lifesciences Consultant Abbott Mitraclip Royalties
More informationPOSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO
POSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO MD (ANAESTHESIOLOGY) FINAL EXAMINATION AUGUST 2013 Date : 2 nd August 2013 Time : 1.00 p.m. 4.00 p.m. Answer any three questions. Answer each question
More informationComparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroscore
Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroscore Marzia Leacche, MD, John G. Byrne, MD, Natalia S. Solenkova,
More informationSupplementary Online Content
Supplementary Online Content Valle JA, Tamez H, Abbott JD, et al. Contemporary use and trends in unprotected left main coronary artery percutaneous coronary intervention in the United States: an analysis
More informationSurgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome
Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Chris C. Cook, MD Associate Professor of Surgery Director, CT Residency Program, WVU ACOI 10/17/18 No Disclosures
More informationOutcomes of Surgical Aortic Valve Replacement in Moderate Risk Patients: Implications for Determination of Equipoise in the Transcatheter Era
Outcomes of Surgical Aortic Valve Replacement in Moderate Risk Patients: Implications for Determination of Equipoise in the Transcatheter Era Sebastian A. Iturra, Rakesh M. Suri, Kevin L. Greason, John
More informationOutline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications?
Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications? Fernando Holguin MD MPH Director, Asthma Clinical & Research Program Center for lungs and Breathing University of Colorado
More informationWhy is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager
Why is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager Co-morbidity in cancer Definition:- Co-morbidity is a disease or illness affecting a cancer patient in addition
More informationPREDICTORS OF PROLONGED HOSPITAL STAY
PREDICTORS OF PROLONGED HOSPITAL STAY IN CARDIAC SURGERY Zuraida Khairudin Faculty of Science Computer and Mathematics, Universiti Teknologi MARA, Malaysia zurai405@salam.uitm.edu.my ABSTRACT quality of
More informationWhy is co-morbidity important for cancer patients? Di Riley Associate Director Clinical Outcomes Programme
Why is co-morbidity important for cancer patients? Di Riley Associate Director Clinical Outcomes Programme Co-morbidity in cancer Definition:- Co-morbidity is a disease or illness affecting a cancer patient
More informationTransfusion and Blood Stream Infections after Coronary Surgery
1 Transfusion and Blood Stream Infections after Coronary Surgery Tuomas Tauriainen, a Eeva-Maija Kinnunen, a Idamaria Laitinen, a Vesa Anttila, b Tuomas Kiviniemi, b Juhani K.E. Airaksinen, b and Fausto
More informationIschemic Ventricular Septal Rupture
Ischemic Ventricular Septal Rupture Optimal Management Strategies Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Disclosures Abbott Mitraclip Royalties Johnson & Johnson Proctor
More informationSUPPLEMENTAL MATERIAL. Supplemental Methods. Duke CAD Index
SUPPLEMENTAL MATERIAL Supplemental Methods Duke CAD Index The Duke CAD index, originally developed by David F. Kong, is an angiographic score that hierarchically assigns prognostic weights (0-100) based
More informationQuality Measures MIPS CV Specific
Quality Measures MIPS CV Specific MEASURE NAME Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy CAHPS for MIPS Clinician/Group Survey Cardiac Rehabilitation Patient Referral from
More information